Cenra Inc. (TPE:3716)

Market Cap	4.80B -14.8%
Revenue (ttm)	8.57B -3.9%
Net Income	300.07M -5.4%
EPS	2.38 -4.0%
Shares Out	146.21M
PE Ratio	13.80
Forward PE	n/a
Dividend	1.02 (3.10%)
Ex-Dividend Date	n/a

Volume	70,466
Average Volume	137,383
Open	32.95
Previous Close	33.25
Day's Range	32.85 - 33.15
52-Week Range	29.00 - 38.70
Beta	n/a
RSI	38.95
Earnings Date	May 13, 2026

About Cenra

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It offers active pharmaceutical ingredients, generic drugs for human use, over to the counter drugs, self-care products for the prevention of diseases, home care and cosmetics, and animal healthcare products. The company is also involved in the research and development, contracting manufacturing and international, and senior care services, as well as distributes and sells pharmaceutical brands. In a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1952
• Employees: 542
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3716

Financial Performance

In 2025, Cenra's revenue was 8.57 billion, a decrease of -3.91% compared to the previous year's 8.92 billion. Earnings were 300.07 million, a decrease of -5.44%.